Our Pricing

Buy Weight Loss Injections Online UK

Published on: June 03, 2026

Looking to buy weight loss injections online UK with transparent pricing and expert clinical support? At Cured Pharmacy, our UK-registered prescribers offer free consultations for licensed treatments including Mounjaro, Wegovy, and Saxenda, with discreet delivery across the UK. All prescription weight loss medications require clinical assessment to ensure they're safe and appropriate for your individual circumstances.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists mimic naturally occurring hormones that regulate appetite and blood sugar levels. These medications slow gastric emptying, increase feelings of fullness after meals, and reduce hunger signals between meals — creating a physiological environment that supports sustainable weight reduction [1].

Clinical trials demonstrate that GLP-1 treatments produce significantly greater weight loss than diet and exercise alone. In the STEP programme, semaglutide (the active ingredient in Wegovy) achieved an average 14.9% body weight reduction over 68 weeks, whilst tirzepatide (Mounjaro) demonstrated up to 22.5% average reduction in the SURPASS trials [1][2].

These medications work best when combined with a reduced-calorie diet and increased physical activity. Your UK prescriber will discuss realistic expectations during your consultation, as individual results vary based on starting weight, adherence, and lifestyle factors.

Comparing Weight Loss Injection Options Available in the UK

Three main injectable treatments are licensed by the MHRA for weight management: tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda). Each works through the GLP-1 pathway, but they differ in potency, dosing frequency, and clinical outcomes [2][3].

Mounjaro represents the newest option, featuring dual GIP/GLP-1 receptor activation that produces the highest average weight reduction in head-to-head trials. Wegovy offers once-weekly dosing with robust clinical evidence from the STEP programme. Saxenda requires daily injections but has the longest real-world safety record, having been prescribed in the UK since 2015 [3].

Your choice depends on multiple factors including your weight loss goals, medical history, tolerance for injection frequency, and budget. Our prescribers assess these considerations during your free consultation to recommend the most suitable option.

Injectable vs Oral Weight Loss Treatments

Injectable GLP-1 medications typically produce greater weight reduction than oral alternatives like Orlistat or Mysimba. Orlistat works by blocking fat absorption in the digestive system, whilst Mysimba combines naltrexone and bupropion to reduce appetite through different brain pathways [4].

Oral treatments may be appropriate if you prefer tablet-based therapy or have contraindications to injectable medications. However, clinical data consistently shows superior outcomes with GLP-1 injections for patients with higher BMI or those who haven't achieved goals with oral treatments [4].

What to Expect During Your Weight Loss Treatment Journey

Treatment typically begins with a starter dose that gradually increases over 8-20 weeks, depending on the specific medication. This titration schedule minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's effects on appetite and digestion [5].

Most patients notice reduced hunger within the first week, though measurable weight loss typically becomes evident after 4-6 weeks. The MHRA recommends discontinuing treatment if you haven't lost at least 5% of your starting weight after 12 weeks at the maintenance dose, as this suggests the medication isn't producing adequate response [5].

Regular follow-up consultations ensure your treatment remains safe and effective. Your prescriber will monitor your progress, adjust dosing if needed, and address any side effects. Successful long-term outcomes require ongoing commitment to dietary changes and physical activity alongside medication.

Common Side Effects and How to Manage Them

Nausea, diarrhoea, and constipation are the most frequently reported side effects, particularly during dose escalation. These symptoms typically improve within 2-4 weeks as your body adjusts. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can help minimise discomfort [6].

Serious side effects are uncommon but require immediate medical attention. Contact your GP or call 111 if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or allergic reactions. Your prescriber will review your full medical history to identify any contraindications before prescribing.

Who Can Use Prescription Weight Loss Injections in the UK

NICE guidelines recommend considering GLP-1 medications for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnoea. Your prescriber will calculate your BMI and assess your medical history during the consultation [7].

These treatments aren't suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy or breastfeeding, and certain gastrointestinal conditions. Your online assessment captures this information to ensure safe prescribing [7].

Patients taking certain medications may require dose adjustments or additional monitoring. Always disclose all current medications, including over-the-counter products and supplements, during your consultation. Our prescribers review potential interactions before approving any prescription.

How to Buy Weight Loss Injections Online UK Through Cured Pharmacy

Our process begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your weight history, medical conditions, current medications, and weight loss goals. This information allows our UK-registered prescribers to assess whether prescription treatment is appropriate for you.

If approved, you'll receive a prescription that our GPhC-registered pharmacy team dispenses using genuine UK-licensed medications. We display transparent pricing before your consultation, so you'll know the exact cost before starting your assessment. All orders are packaged discreetly and delivered via tracked courier.

Your treatment includes ongoing prescriber support through our clinical team. You can request follow-up consultations to discuss progress, adjust dosing, or address concerns. We're available by phone on 116 4646009 during business hours, and our superintendent pharmacist Tarun Kumar oversees all clinical services.

Why Choose Cured Pharmacy for Weight Loss Treatment

As a fully registered UK pharmacy (GPhC 9012511), we provide only genuine MHRA-licensed medications dispensed by qualified pharmacists. Unlike some online services, we show pricing upfront before you complete your consultation, with no hidden fees or subscription traps.

Our clinical team has supported thousands of UK patients through their weight loss journeys. We guarantee the lowest prices in the UK market, and every prescription is reviewed by experienced prescribers who follow current NICE and MHRA guidance. Your treatment is delivered in completely discreet packaging with no external branding.

Maintaining Weight Loss After Stopping Injectable Treatment

Clinical evidence shows that most patients regain some weight after discontinuing GLP-1 medications, as the appetite-suppressing effects resolve once treatment stops. The STEP-4 trial found that participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year [8].

Long-term success requires establishing sustainable lifestyle changes during treatment. Focus on building habits around portion control, regular physical activity, and behavioural strategies that you can maintain independently. Many patients benefit from transitioning to structured weight management programmes or dietetic support before discontinuing medication [8].

Some individuals may require ongoing treatment to maintain their weight loss, similar to how other chronic conditions need continued medication. Your prescriber can discuss whether extended treatment is appropriate based on your response, tolerance, and weight-related health improvements.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Glucagon-like peptide-1 (GLP-1) receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(8). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
7. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management [CG189]. NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
8. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, diet, and physical activity levels.